SciTech developing cancer drug in Detroit's TechTown, plans to hire 10 people

SciTech is working on a drug that promises to be a versatile weapon in the fight against cancer ...and fight for job-creating businesses in Detroit.

Excerpt:

SciTech Development sees a bright future for the drug it is working on as both a cancer fighter and an economic driver.

The Wayne State University and Karmanos Cancer Institute spin-off is working on making the drug fenretinide reach its full potential as a cancer fight agent. The seven-person firm has been working on this at TechTown since 2001 and sees it realizing its large upside within the next three years.

Read the rest of the story here.
Enjoy this story? Sign up for free solutions-based reporting in your inbox each week.